NU SKIN ENTERPRISES, INC. Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination
NU SKIN ENTERPRISES, INC. (NUS) reported Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination of $171.38 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-01.
Discontinued › Notes › Business Combinations › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree
us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1 · last filed 2020-02-13
- NU SKIN ENTERPRISES, INC. business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2019-03-31 was $171.38M, a 0.00% change year-over-year.
- NU SKIN ENTERPRISES, INC. business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2018-12-31 was $0.00.
- NU SKIN ENTERPRISES, INC. business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2018-09-30 was $0.00.
- NU SKIN ENTERPRISES, INC. business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2018-06-30 was $0.00.
- NU SKIN ENTERPRISES, INC. business combination, consideration transferred, including equity interest in acquiree held prior to combination for fiscal 2018 was $171.38M.
| Period end | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 3 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 6 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 9 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 12 month |
|---|---|---|---|---|
| 2019-03-31 | $171.38M 10-Q · filed 2019-05-01 | $171.38M derived: sum of 2 quarters · filed 2020-02-13 | $171.38M derived: sum of 3 quarters · filed 2020-02-13 | $171.38M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 derived: sum of 3 quarters · filed 2020-02-13 | $171.38M 10-K · filed 2020-02-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $171.38M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $171.38M 10-Q · filed 2018-08-03 | ||
| 2018-03-31 | $171.38M 10-Q · filed 2018-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |